NCT02025660View on ClinicalTrials.gov

Efficacy of Mw Vaccine in Treatment of Severe Sepsis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2014

Conditions
Severe SepsisSeptic ShockImmune Modulation
Interventions
DRUG

Mw, 0.3ml x three days sc

DRUG

Placebo

Trial Locations (1)

160012

PIMER, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT02025660 - Efficacy of Mw Vaccine in Treatment of Severe Sepsis | Biotech Hunter | Biotech Hunter